Repaglinide for adolescents with cystic fibrosis-related diabetes

Trial Profile

Repaglinide for adolescents with cystic fibrosis-related diabetes

Withdrawn prior to enrolment
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 11 Mar 2015

At a glance

  • Drugs Repaglinide (Primary) ; Insulin
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Feb 2008 The expected completion date for this trial is now 1 Aug 2007.
    • 16 Nov 2007 Status changed from initiated to discontinued (unable to recruit any patients).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top